logo
Sign in

DERM Stock Price, Chart, Stats & News

Journey Medical Corporation
Save

Journey Medical Corporation (DERM) does not currently pay a dividend.

190.45M
Market cap
Current P/E
212.77x
Forward P/E

DERM chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
59.29%
Operating margin
-13.21%
Pretax margin
-18.38%
Net margin
-18.48%
Effective tax rate
-0.53%
ROA
-12.08%
ROE
-46.40%
D/E
0.00x
Interest coverage ratio
-2.21x

DERM valuation

P/E
P/S
1.81x
P/B
3.52x
P/CF
-8.95x
P/FCF
-8.95x
P/OCF
-8.95x
PEG
0.29x
EV multiple
-35.56x

About

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Similar securities

Based on sector and market capitalization

Report issue